PharmaEssentia - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsPharmaEssentia

PharmaEssentia

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Besremi	Ropeginterferon alfa-2b	2021-11-12		Polycythemia vera

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

myelodysplastic syndromes

,

pharmacokinetics

,

invasive hydatidiform mole

,

thoracic neoplasms

,

male breast neoplasms

,

parkinson disease

,

nerve degeneration

,

pancreatic neoplasms

,

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

,

castration-resistant prostatic neoplasms

,

,

brain neoplasms

,

,

non-hodgkin lymphoma

,

follicular lymphoma

,

colonic neoplasms

,

neuroendocrine tumors

,

,

pancreatic ductal carcinoma

,

microsatellite instability

,

,

,

urethral neoplasms

,

ureteral neoplasms

,

,

mouth neoplasms

,

oropharyngeal neoplasms

,

t-cell lymphoma

,

t-cell lymphoma peripheral

,

,

,

myeloid leukemia acute

,

hypersensitivity

,

adenocarcinoma of lung

,

epstein-barr virus infections

,

histiocytic sarcoma

,

follicular dendritic cell sarcoma

,

interdigitating dendritic cell sarcoma

,

salivary gland neoplasms

,

thyroid neoplasms

,

,

carcinoid tumor

,

vulvar neoplasms

,

parotid neoplasms

,

reactive arthritis

,

central nervous system neoplasms

,

spinal cord neoplasms

,

,

,

,

nervous system diseases

,

neoplasms by histologic type

,

nerve tissue neoplasms

,

neuroepithelial neoplasms

,

neuroectodermal tumors

,

,

pelvic neoplasms

,

,

sezary syndrome

,

mycosis fungoides

,

t-cell lymphoma cutaneous

,

,

hematologic diseases

,

b-cell chronic lymphocytic leukemia

,

bone marrow diseases

,

intestinal neoplasms

,

gastrointestinal neoplasms

,

digestive system neoplasms

,

,

,

,

malignant fibrous histiocytoma

,

basal cell carcinoma

,

basal cell neoplasms

,

kidney diseases

,

unknown primary neoplasms

,

endometrioid carcinoma

,

cutaneous malignant melanoma

,

inflammatory breast neoplasms

,

,

colonic diseases

,

x-linked bulbo-spinal atrophy

,

laryngeal neoplasms

,

hypopharyngeal neoplasms

,

nasopharyngeal carcinoma

,

,

,

environmental biomarkers

,

,

local neoplasm recurrence

,

rectal neoplasms

,

adenoviridae infections

,

gastrointestinal stromal tumors

,

uveal neoplasms

,

,

,

,

renal cell carcinoma

,

colorectal neoplasms

,

triple negative breast neoplasms

,

breast neoplasms

,

neoplasm metastasis

,

squamous cell carcinoma

,

head and neck neoplasms

,

ovarian neoplasms

,

stomach neoplasms

,

liver neoplasms

,

urinary bladder neoplasms

,

,

endometrial neoplasms

,

hepatocellular carcinoma

,

prostatic neoplasms

,

esophageal neoplasms

,

hodgkin disease

,

small cell lung carcinoma

,

uterine cervical neoplasms

,

transitional cell carcinoma

,

,

squamous cell neoplasms

,

multiple myeloma

,

urologic neoplasms

,

esophageal squamous cell carcinoma

,

ovarian epithelial carcinoma

,

biliary tract neoplasms

,

fallopian tube neoplasms

,

kidney neoplasms

,

cholangiocarcinoma

,

nasopharyngeal neoplasms

,

plasma cell neoplasms

,

bile duct neoplasms

,

gallbladder neoplasms

,

merkel cell carcinoma

,

malignant mesothelioma

,

peritoneal neoplasms

,

hematologic neoplasms

,

non-small-cell lung carcinoma

,

,

squamous cell carcinoma of head and neck

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use